Tysabri every eight weeks may cut PML risk
Tysabri every eight weeks may cut PML risk
Preliminary findings from an ongoing study of multiple sclerosis patients suggest the dosing interval for Tysabri can be as much as doubled from the label-recommended standard without sacrificing efficacy, and with potentially less risk of progressive multifocal leukoencephalopathy (PML) -- even among patients with more than average PML risk, researchers claim... Read More - http://www.ms-uk.org/MSnews
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 2285 Views
-
Last post by NHE
-
- 6 Replies
- 6269 Views
-
Last post by ElliotB
-
- 0 Replies
- 1320 Views
-
Last post by NHE
-
- 0 Replies
- 3402 Views
-
Last post by NHE
-
- 1 Replies
- 1014 Views
-
Last post by NHE
-
- 1 Replies
- 1509 Views
-
Last post by NHE
-
- 11 Replies
- 3329 Views
-
Last post by NHE
-
- 0 Replies
- 3154 Views
-
Last post by NHE
-
- 0 Replies
- 1334 Views
-
Last post by NHE